Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Infectious diseases
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Therapy areas
Infectious diseases
Infectious diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Infectious diseases
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord Pharma
Firstwordpharma News
-
October 31, 2020
Infectious diseases
New TEPEZZA (teprotumumab-trbw) Data to Be Presented at the American Academy of Ophthalmology 2020 Annual Meeting – FirstWord Pharma
Infectious diseases
FTC nod clears way for merger between Pfizer’s Upjohn unit, Mylan – FirstWord Pharma
Infectious diseases
High-Dose Quadrivalent Influenza Vaccine Shows Favourable Phase 2 Trial Results in Children: Presented at ESPID – FirstWord Pharma
Infectious diseases
Novel Scoring System Differentiates Viral From Bacterial Pneumonia in Hospitalised Children: Presented at ESPID – FirstWord Pharma
Infectious diseases
BCG Vaccination at Birth Reduces Incidence of Non-Tuberculosis Infections in Newborns:...
Firstwordpharma News
-
October 31, 2020
0
Infectious diseases
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases – FirstWord...
Firstwordpharma News
-
October 31, 2020
0
Infectious diseases
China’s Clover applies for Philippines COVID-19 vaccine trial – FirstWord Pharma
Firstwordpharma News
-
October 31, 2020
0
Infectious diseases
Election Implications for the U.S. and Global COVID-19 Response
Biospace News
-
October 30, 2020
0
Infectious diseases
Mytide Therapeutics Launches with Novel Platform that Automates Peptide Manufacturing and...
Biospace News
-
October 30, 2020
0
1
2
3
...
60
Page 1 of 60
- Advertisement -
MOST POPULAR
Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results Nasdaq:SLRX
March 23, 2020
Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund...
December 18, 2019
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for...
June 13, 2019
Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies...
March 28, 2019
Load more
HOT NEWS
Deals
Bristol-Myers Squibb Announces Filing of Definitive Proxy Statement in Connection with...
Approval
India’s First New Discovery Antibiotics from Wockhardt Granted Indian Regulatory Approval
Commercial
Ketamine Infusion in ICU Improves Pain, Sedation Without Delirium: Presented at...
Others
Sphere Fluidics Expands Commercial Operations to Increase Supply of Pico-Surf Surfactant...
